Stock Analysis

Taki Chemical Third Quarter 2024 Earnings: EPS: JP¥44.11 (vs JP¥10.16 in 3Q 2023)

TSE:4025
Source: Shutterstock

Taki Chemical (TSE:4025) Third Quarter 2024 Results

Key Financial Results

  • Revenue: JP¥8.29b (up 11% from 3Q 2023).
  • Net income: JP¥374.0m (up 325% from 3Q 2023).
  • Profit margin: 4.5% (up from 1.2% in 3Q 2023). The increase in margin was driven by higher revenue.
  • EPS: JP¥44.11 (up from JP¥10.16 in 3Q 2023).
earnings-and-revenue-history
TSE:4025 Earnings and Revenue History November 17th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Taki Chemical shares are down 5.5% from a week ago.

Balance Sheet Analysis

Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. See our latest analysis on Taki Chemical's balance sheet health.

Valuation is complex, but we're here to simplify it.

Discover if Taki Chemical might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.